No association between serum insulin-like growth factor (IGF)-I, IGF-binding protein-3, and lung cancer risk.
Ahn
Jiyoung
J
Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, EPS-3044, 9000 Rockville Pike, Bethesda, MD 20892, USA.
Weinstein
Stephanie J
SJ
Snyder
Kirk
K
Pollak
Michael N
MN
Virtamo
Jarmo
J
Albanes
Demetrius
D
D000368:Aged; D014408:Biomarkers, Tumor / Q000097:blood; D001827:Body Height; D015992:Body Mass Index; D016022:Case-Control Studies; D002149:Energy Intake; D004797:Enzyme-Linked Immunosorbent Assay; D005387:Finland / Q000453:epidemiology; D005500:Follow-Up Studies; D006801:Humans; D018972:Insulin-Like Growth Factor Binding Protein 3 / Q000097:blood*; D007334:Insulin-Like Growth Factor I / Q000378:metabolism*; D016014:Linear Models; D016015:Logistic Models; D008175:Lung Neoplasms / Q000097:blood* / Q000453:epidemiology* / Q000473:pathology; D008297:Male; D008875:Middle Aged; D009043:Motor Activity; D015999:Multivariate Analysis; D009367:Neoplasm Staging; D011446:Prospective Studies; D012307:Risk Factors
D014408:Biomarkers, Tumor; D018972:Insulin-Like Growth Factor Binding Protein 3; D007334:Insulin-Like Growth Factor I